Skip to main content
  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective." measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.
No Filters Selected
          For the filters below, open and close each one at a time for the best experience
          CBE ID Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          0220 Adjuvant hormonal therapy is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0 or Stage IB – Stage III hormone receptor positive breast cancer American College of Surgeons Endorsed
          0221 Needle biopsy to establish diagnosis of cancer precedes surgical excision/resection American College of Surgeons Endorsement Removed
          0559 Combination chemotherapy or chemo-immunotherapy (if HER2 positive), is recommended or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0 or stage IB - III hormone receptor negative breast cancer American College of Surgeons Endorsement Removed
          0534 Hospital specific risk-adjusted measure of mortality or one or more major complications within 30 days of a lower extremity bypass (LEB). American College of Surgeons Endorsement Removed
          0223 Adjuvant chemotherapy is recommended, or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer American College of Surgeons Endorsed
          0224 Completeness of pathology reporting American College of Surgeons Endorsement Removed
          0706 Risk Adjusted Colon Surgery Outcome Measure American College of Surgeons Endorsement Removed
          0225 At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer American College of Surgeons Endorsement Removed
          0076 Optimal Vascular Care MN Community Measurement Endorsed
          1884 Depression Response at Six Months- Progress Towards Remission MN Community Measurement Endorsed
          Displaying 11 - 20 of 1215

          The Submission Tool and Repository (STAR) is a measure database of quality performance measures that have been submitted to the previous consensus-based entity for endorsement review. The STAR database will be updated regularly as new and maintenance measures are submitted to the Partnership for Quality Measurement for endorsement review. Battelle will be providing additional enhancements to the STAR database as measure information is submitted in order to better support the accessibility of timely and accurate measure information for all interested parties.